fbpx
QQQ
+ 0.00
341.24
+ 0%
DIA
-0.07
345.19
-0.02%
SPY
+ 0.05
424.26
+ 0.01%
TLT
+ 0.00
142.31
+ 0%
GLD
-0.04
175.78
-0.02%

Why Affimed Is Trading Higher Today

March 31, 2021 9:56 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In Affimed's Stock Today

Affimed's (NASDAQ:AFMD) stock has been rising Wednesday, up 5.92% to a price of $7.73. The stock's volume is currently 233.69 thousand, which is roughly 11.73% of its recent 30-day volume average of 1.99 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Affimed shares are trading higher after the company announced FDA clearance of its IND application to study the combination of AFM24 with SNK-01 natural killer cell therapy in solid tumors.

Insights On Recent Price Action

The stock's 50-day moving average was $6.47 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $8.6 and fallen to a low of $1.5.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

Affimed Shares See Volume; Traders Circulate Report Titled 'NK cells with bispecific antibody show activity against lymphoma cells'

https://www.mdanderson.org/newsroom/nk-cells-bispecific-antibody-show-activity-against-lymphoma-cells.h00-159460845.html read more

Affimed Shares Tick Higher; Hearing Wells Fargo Sets $18 Price Target

Stocks That Hit 52-Week Highs On Monday

    During Monday's morning trading, 363 companies set new 52-week highs. read more

Stocks That Hit 52-Week Highs On Friday

    On Friday morning, 152 companies hit new 52-week highs. read more